—
/100
Partial
○ Unscored 1⁄4
negative-results-mcp
Negative results intelligence for drug discovery: inactive compounds, failed selectivity panels, terminated clinical trials, failed CRISPR screens, antibody developability failures, and more — each result carrying full provenance (source database, DOI/PMID, license)
Unscored visibility
— 1/4 applicable dimensions scored
○ Schema Quality
○ Protocol
— Reliability
○ Docs & Maintenance
✓ Security Hygiene
— Schema Interpretability
A remote probe is needed for Protocol and Reliability scores.
Schema Quality
—
25% weight
Protocol Compliance
—
20% weight
Reliability
—
20% weight
Docs & Maintenance
—
15% weight
Security Hygiene
81
20% weight
Score History
Category Trends
30-Day Uptime
30 days ago
Today